GAMMA Investing’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$400K Buy
3,051
+164
+6% +$21K 0.01% 831
2026
Q2
$547K Sell
2,887
-38
-1% -$5.64K 0.02% 612
2026
Q1
$272K Buy
2,925
+16
+0.6% +$1.42K 0.01% 908
2025
Q4
$234K Buy
2,909
+69
+2% +$5.78K 0.01% 927
2025
Q3
$277K Buy
2,840
+68
+2% +$5.48K 0.02% 764
2025
Q2
$193K Buy
2,772
+1,196
+76% +$68.2K 0.01% 946
2025
Q1
$78.3K Buy
1,576
+742
+89% +$46.9K 0.01% 1454
2024
Q4
$58.3K Sell
834
-165
-17% -$13.7K 0.01% 1542
2024
Q3
$105K Buy
999
+271
+37% +$31.7K 0.01% 968
2024
Q2
$104K Buy
728
+462
+174% +$53.3K 0.01% 759
2024
Q1
$29.7K Buy
266
+139
+109% +$16.6K 0.01% 1379
2023
Q4
$16.5K Buy
+127
New +$17.5K ﹤0.01% 1619

Other funds holding ACLS

GAMMA Investing's ACLS Position: Q3 2026 in Review

GAMMA Investing increased its Axcelis (ACLS) stake by 5.7% in Q3 2026, buying an estimated $21K and bringing the position to 3,051 shares worth $400K. The position accounts for 0.01% of the portfolio, ranked #831.

GAMMA Investing first reported a position in ACLS in Q4 2023 and has held it in 12 quarters since. The position peaked at $547K in Q2 2026. 13 funds tracked by Wall St. Rank hold ACLS as of Q3 2026.

  • GAMMA Investing held 3,051 shares of Axcelis worth $400K as of Q3 2026.
  • GAMMA Investing bought 164 Axcelis shares in Q3 2026, an estimated $21K.
  • Axcelis made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #831 holding.
  • GAMMA Investing first reported a position in Axcelis in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Axcelis position peaked at $547K in Q2 2026.
  • 13 funds tracked by Wall St. Rank held Axcelis as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.